Met Life Investment Management, LLC Assertio Holdings, Inc. Transaction History

Met Life Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 09, 2024	BUY	$2.52 - $5.69 $118,253 - $267,008	46,926 New	46,926 $120,000
Q3 2023 Apr 29, 2024	BUY	$2.52 - $5.69 $44,508 - $100,496	17,662 Added 60.35%	46,926 $120,000
Q3 2023 Nov 14, 2023	BUY	$2.52 - $5.69 $44,508 - $100,496	17,662 Added 60.35%	46,926 $120,000
Q2 2023 Apr 29, 2024	BUY	$5.0 - $7.66 $146,320 - $224,162	29,264 New	29,264 $158,000
Q2 2023 Aug 10, 2023	BUY	$5.0 - $7.66 $146,320 - $224,162	29,264 New	29,264 $158,000

31M

957K

38.5K

Ticker ASRT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 48,178,200
Market Cap $40.5M
Description
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.